Roivant Sciences Overview
Roivant Sciences Target Price
Analysts' 12-month price predictions for ROIV.
Get informed when a big investor buys or sells
+ FollowShare Price
$34.91
Average Target Price
$39.75
13.9% upside
13.9% upside4 analysts in the last 4 months
High: $42 | Low: $36
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | GuggenheimYastin Suneja | $36 | 3.1% upside |  |
| 2026-05-21 | Cowen & Co. | $41 | 17.4% upside | |
| 2026-05-21 | Leerink PartnersDavid Risinger | $42 | 20.3% upside | |
| 2026-04-16 | Piper Sandler | $40 | 14.6% upside | |
| 2026-03-04 | H.C. WainwrightDouglas Tsao | $34 |  2.6% downside | |
| 2026-02-10 | H.C. Wainwright | $33 | 5.5% downside | |
| 2026-02-09 | Jefferies | $30 | 14.1% downside | |
| 2026-02-09 | Guggenheim | $30 | 14.1% downside | |
| 2025-12-18 | Guggenheim | $28 | 19.8% downside | |
| 2025-12-15 | Leerink PartnersDavid Risinger | $32 | 8.3% downside | |
| 2025-12-12 | H.C. Wainwright | $26 | 25.5% downside | |
| 2025-11-14 | GuggenheimYastin Suneja | $25 | 28.4% downside | |
| 2025-11-11 | Leerink PartnersDavid Risinger | $29 | 16.9% downside | |
| 2025-09-18 | Jefferies | $20 | 42.7% downside | |
| 2025-09-18 | Guggenheim | $21 | 39.8% downside | |
| 2025-09-18 | H.C. Wainwright | $20 | 42.7% downside | |
| 2024-10-21 | Leerink PartnersDavid Risinger | $17 | 51.3% downside | |
| 2024-09-19 | Goldman SachsCorinne Jenkins | $17 | 51.3% downside | |
| 2024-09-11 | Bank of America SecuritiesChi Fong | $12.5 | 64.2% downside | |
| 2024-05-31 | Piper SandlerAllison Bratzel | $20 | 42.7% downside | |
| 2024-04-03 | H.C. WainwrightDouglas Tsao | $18 | 48.4% downside | |
| 2024-04-03 | Deutsche BankNeena Bitritto-Garg | $15 | 57% downside | |
| 2024-04-02 | Goldman SachsCorinne Jenkins | $18 | 48.4% downside | |
| 2024-03-13 | Goldman SachsCorinne Jenkins | $16 | 54.2% downside | |
| 2023-01-05 | Citigroup | $14 | 59.9% downside | |
| 2022-12-19 | Leerink Partners | $10 | 71.4% downside | |
| 2022-08-18 | Citigroup | $10 | 71.4% downside | |
| 2022-05-24 | Goldman Sachs | $12 | 65.6% downside | |